Critical cancer drug shortage forces doctors, patients to make tough choices

Hospitals and cancer centers are running out of two major injectable cancer drugs: carboplatin and cisplatin. Dr. Eleonora Teplinsky, head of breast medical oncology for the Valley Health System in New Jersey, joins Ali Rogin to discuss the causes and effects of the shortages, and the dilemmas that providers and their patients now face.

Read the Full Transcript

Notice: Transcripts are machine and human generated and lightly edited for accuracy. They may contain errors.

Listen to this Segment